D026

DRUG2 trials

Sponsors

Chong Kun Dang Pharmaceutical

Conditions

GERD

Phase 1

A Study to Compare PK, PD and Safety of CKD-381 and D026 in Healthy Subjects

CompletedNCT03558425

Chong Kun Dang PharmaceuticalGERD

Start: 2018-06-27End: 2018-09-14Updated: 2018-10-12

A Study to Compare PK, PD and Safety of CKD-382 in Healthy Subjects

Chong Kun Dang PharmaceuticalGERD

Start: 2020-09-25End: 2021-09-30Target: 48Updated: 2021-01-11